ACI 3rd Annual Life Sciences AI Summit
Conference Focus
Legal and regulatory realities of AI in life sciences, FDA/EU compliance, IP, data governance
Overview
The ACI 3rd Annual Life Sciences AI Summit is a premier forum dedicated to the complex legal and regulatory landscape surrounding artificial intelligence in the pharmaceutical and biotechnology sectors. Organized by the American Conference Institute, this event brings together legal counsel, regulatory experts, and industry leaders to navigate the evolving challenges of AI integration. The summit focuses on critical issues such as FDA and EU compliance, intellectual property protection, data governance, and ethical AI deployment. It is uniquely positioned to bridge the gap between rapid technological innovation and the stringent legal frameworks required for life sciences, ensuring that organizations can leverage AI while mitigating risk.
Why Attend
Professionals should attend to gain actionable insights into the shifting regulatory environment for AI. The summit offers unparalleled networking with legal and compliance experts, providing a strategic advantage in navigating intellectual property hurdles and data privacy requirements. Attendees will leave with a clearer understanding of how to align AI-driven R&D and clinical processes with global regulatory expectations, ultimately fostering innovation while maintaining compliance.
Key Topics & Sessions
- •FDA and EMA regulatory frameworks for AI-enabled medical devices
- •Intellectual property strategies for AI-generated inventions
- •Data governance and privacy compliance in AI training
- •Managing liability in AI-driven clinical trials
- •Ethical considerations and bias mitigation in AI models
- •Cross-border data transfer regulations
- •AI in drug discovery and development legal risks
- •Contractual considerations for AI vendor partnerships
- •Post-market surveillance and AI algorithm updates
- •Preparing for future AI-specific legislation
Who Should Attend
Conference History
The American Conference Institute (ACI) has a long-standing reputation for producing high-level legal and regulatory conferences. This specific summit series was established to address the urgent, specialized intersection of AI and life sciences law, reflecting the industry's rapid adoption of these technologies over the past few years.
Venue & Location
New York City Bar Association, located in the heart of New York City, NY.
Related Conference Categories
This conference covers topics in the following pharma and life sciences domains. Explore more events in each category using our conference directory filters.
Resources & Links
About ACI 3rd Annual Life Sciences AI Summit
ACI 3rd Annual Life Sciences AI Summit is a in-person event scheduled for 2026-02-24 to 2026-02-25 in New York City Bar Association, New York, NY. The conference focuses on legal and regulatory realities of ai in life sciences, fda/eu compliance, ip, data governance. This event is categorized under AI & Machine Learning in Pharma, Regulatory & Compliance in our conference directory.
The ACI 3rd Annual Life Sciences AI Summit is a premier forum dedicated to the complex legal and regulatory landscape surrounding artificial intelligence in the pharmaceutical and biotechnology sectors. Organized by the American Conference Institute, this event brings together legal counsel, regulatory experts, and industry leaders to navigate the evolving challenges of AI integration. The summit focuses on critical issues such as FDA and EU compliance, intellectual property protection, data governance, and ethical AI deployment. It is uniquely positioned to bridge the gap between rapid technological innovation and the stringent legal frameworks required for life sciences, ensuring that organizations can leverage AI while mitigating risk.
Professionals attending conferences like ACI 3rd Annual Life Sciences AI Summit gain access to cutting-edge insights, peer networking, and exposure to the latest technologies shaping the pharmaceutical and biotechnology sectors. Whether you are evaluating new vendors, seeking regulatory updates, or expanding your professional network, industry conferences remain one of the most effective ways to stay current in life sciences.
AI and machine learning continue to transform the pharmaceutical industry, from drug discovery to commercial operations. Conferences featuring AI content provide valuable exposure to real-world implementations and emerging capabilities. Explore our Pharmaceutical GenAI Tracker for a comprehensive view of AI deployments across the industry.
Regulatory conferences are essential for staying current with evolving requirements from the FDA, EMA, and other global regulatory bodies. Understanding compliance frameworks such as 21 CFR Part 11 and ICH guidelines is critical for pharmaceutical software development and validation.
Looking for guidance on which conferences to attend or how to build your event strategy for 2026? Book a meeting with the IntuitionLabs team to discuss your priorities and how we can support your team.